网站大量收购独家精品文档,联系QQ:2885784924

从生产者角度分析药品临床供应短缺的原因-中国药事.PDF

从生产者角度分析药品临床供应短缺的原因-中国药事.PDF

  1. 1、本文档共4页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
从生产者角度分析药品临床供应短缺的原因-中国药事

596 中国药事 2017 年 6 月 第 31 卷 第 6 期 从生产者角度分析药品临床供应短缺的原因 * 周振,冯国忠 (中国药科大学国际医药商学院,南京 211198) 摘要 目的 : 从生产者角度分析药品短缺原因,提出应对药品短缺问题的政策建议。方法:采用文献综 述法和归纳总结法,分析药品短缺原因;在此基础上提出相关建议。结果与结论:对于药品生产企业来 说,药品短缺原因分为生产原因和非生产原因。生产性原因分为主观原因和客观原因。主观原因主要有 价格太低、需求量少、成本上升等造成企业不愿生产;客观原因主要有原料获取困难、生产条件不符合 规定等。非生产性原因主要有流通环节利润太低、流通垄断、意外情况等。应进一步调动生产企业积极 性、净化原料和流通环节、落实保障政策,提高相应药品的可及性。 关键词: 生产企业;药品短缺;利润;价格;原料获取;流通渠道;政策建议 中图分类号:R95 文献标识码:A 文章编号: 1002-7777(2017)06-0596-04 doi:10.16153/j.1002-7777.2017.06.002 Analysis of the Causes of Shortage of Clinical Drug Supply from the Viewpoint of Manufacturers * Zhou Zhen, Feng Guozhong (College of International Medical Business, China Pharmaceutical University, Nanjing 211198, China) Abstract Objective: To analyze the causes of drug shortage from the viewpoint of manufacturer and put forward policy suggestions to deal with the drug shortage. Methods: The causes of drug shortage were analyzed using methods of literature review and induction, and relevent suggestions were put forward. Results and Conclusion: As far as drug manufacturers are concerned, the causes of drug shortage are divided into production reasons which are divided into subjective reasons and objective reasons and non-production reasons which include low distribution profit, distribution monopoly, accidents and so on. The main subjective reasons include too low prices, low demand, as well as rising costs, with the result that manufacturers are unwilling to produce. The main objective reasons include the shortage of raw materials and the unqualified requirements for production conditions. Government should further mobilize the enthusiasm of drug manufacturers, clarification of raw material market and distribution, implement security policies and other measures to improve the accessibility of the corresponding drugs. Keywords: manufact

文档评论(0)

xiaozu + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档